32 firms’ operating profits fall in 2011

Published: 2012-03-26 07:00:00

Updated: 2012-03-26 07:00:00

Korea's 32 drug firms posting more than 100 billion won in annual sales saw their operating profits decline in 2011 due to sluggish sales that might be affected by the government’s aggressive policy to eliminate the prevailing illegal rebate, an online market watchdog said recently.

According ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK